Paper24434331
Novel adjuvants & delivery vehicles for vaccines development: a road ahead.
Mohan T and 2 others. Indian J Med Res, 2013. Cited by 144 papers, by iCite.
Cite this record
ConductScience Library. Novel adjuvants & delivery vehicles for vaccines development: a road ahead. Papers, record 24434331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24434331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adjuvants, Immunologic | Major topic |
| Adjuvants, Pharmaceutic | Major topic |
| Drug Delivery Systems | Major topic |
| Vaccines | Major topic |
| Clinical Trials as Topic | |
| Drug Discovery | |
| Humans | |
| Immunity, Humoral | |
| Lipopolysaccharides | |
| Liposomes | |
| T-Lymphocytes, Cytotoxic |
Source PubMed
References104
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23151505 | Merck Ad5/HIV induces broad innate immune activation that predicts CD8⁺ T-cell responses but is attenuated by preexisting Ad5 immunity. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/23151505 | PubMed |
| 2 | 20371470 | Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. | Sci Transl Med | 2010 | https://conductscience.org/library/papers/20371470 | PubMed |
| 3 | 10887315 | Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. | J Allergy Clin Immunol | 2000 | https://conductscience.org/library/papers/10887315 | PubMed |
| 4 | 11528034 | Institutional Policies and Guidelines on Adjuvants and Antibody Production. | ILAR J | 1995 | https://conductscience.org/library/papers/11528034 | PubMed |
| 5 | 18272264 | Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. | Vaccine | 2008 | https://conductscience.org/library/papers/18272264 | PubMed |
| 6 | 15479434 | Vaccine adjuvants: current state and future trends. | Immunol Cell Biol | 2004 | https://conductscience.org/library/papers/15479434 | PubMed |
| 7 | 17240491 | The utility of ISCOMATRIX adjuvant for dose reduction of antigen for vaccines requiring antibody responses. | Vaccine | 2007 | https://conductscience.org/library/papers/17240491 | PubMed |
| 8 | 20822351 | Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. | Expert Rev Vaccines | 2010 | https://conductscience.org/library/papers/20822351 | PubMed |
| 9 | 19995959 | Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells. | J Exp Med | 2009 | https://conductscience.org/library/papers/19995959 | PubMed |
| 10 | 20099123 | Micro/nanoparticle adjuvants: preparation and formulation with antigens. | Methods Mol Biol | 2010 | https://conductscience.org/library/papers/20099123 | PubMed |
| 11 | 23674894 | Cellular uptake mechanism and intracellular fate of hydrophobically modified pullulan nanoparticles. | Int J Nanomedicine | 2013 | https://conductscience.org/library/papers/23674894 | PubMed |
| 12 | 17109335 | Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector. | J Infect Dis | 2006 | https://conductscience.org/library/papers/17109335 | PubMed |
| 13 | 19416838 | Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19416838 | PubMed |
| 14 | 15032578 | Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. | Annu Rev Immunol | 2004 | https://conductscience.org/library/papers/15032578 | PubMed |
| 15 | 12626528 | Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells. | J Immunol | 2003 | https://conductscience.org/library/papers/12626528 | PubMed |
| 16 | 18194079 | Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients. | Expert Opin Biol Ther | 2008 | https://conductscience.org/library/papers/18194079 | PubMed |
| 17 | 3276445 | Future prospects for vaccine adjuvants. | Crit Rev Immunol | 1988 | https://conductscience.org/library/papers/3276445 | PubMed |
| 18 | 17310844 | IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances. | J Exp Clin Cancer Res | 2006 | https://conductscience.org/library/papers/17310844 | PubMed |
| 19 | 21506635 | ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation. | Expert Rev Vaccines | 2011 | https://conductscience.org/library/papers/21506635 | PubMed |
| 21 | 15620476 | Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. | Vaccine | 2005 | https://conductscience.org/library/papers/15620476 | PubMed |
Cited by84
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 144 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42347628 | Viral Vaccine Adjuvant Strategies for Shaping Durable Immunity Across the Human Lifespan. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42347628 | PubMed |
| 41971084 | Sodium New Houttuyfonate: a comprehensive review of pharmacological advances in antimicrobial, antitumor, and adjuvanticity effects. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41971084 | PubMed |
| 41142061 | Delivery and adjuvant: liposomes for SARS-CoV-2 vaccines. | BioTechnologia (Pozn) | 2025 | https://conductscience.org/library/papers/41142061 | PubMed |
| 41007442 | Induction of Sustained Immunity Following Vaccination with Live Attenuated Trypanosoma cruzi Parasites Combined with Saponin-Based Adjuvants. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/41007442 | PubMed |
| 40849649 | Reverse vaccinology-based identification and in silico characterization of immunogenic membrane proteins of Salmonella Typhimurium as novel vaccine targets against multidrug-resistant infections. | BMC Microbiol | 2025 | https://conductscience.org/library/papers/40849649 | PubMed |
| 40722102 | Study on immunogenicity of recombinant ferritin hemagglutinin of canine distemper virus. | Virol J | 2025 | https://conductscience.org/library/papers/40722102 | PubMed |
| 40573952 | Vaccination Strategies and Research Gaps in Hepatitis E Virus for Special Populations. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40573952 | PubMed |
| 40554485 | Exploring varicella zoster virus proteome for construction and validation of a multi-epitope based subunit vaccine using multifaceted immunoinformatics approaches. | PLoS One | 2025 | https://conductscience.org/library/papers/40554485 | PubMed |
| 40535033 | In Vitro Evaluation of Flame-Made Calcium Phosphate Nanoparticles for Antigen Delivery and Immunostimulation. | ACS Appl Nano Mater | 2025 | https://conductscience.org/library/papers/40535033 | PubMed |
| 40510294 | Lipopeptide Hydrogel Possesses Adjuvant-Like Properties for the Delivery of the GPC-3 Peptide-derived Antigen. | Adv Funct Mater | 2025 | https://conductscience.org/library/papers/40510294 | PubMed |
| 40433372 | Comprehensive immunoinformatics and bioinformatics strategies for designing a multi-epitope based vaccine targeting structural proteins of Nipah virus. | Front Immunol | 2025 | https://conductscience.org/library/papers/40433372 | PubMed |
| 40313573 | Nanotechnology-based strategies for vaccine development: accelerating innovation and delivery. | Biomater Transl | 2025 | https://conductscience.org/library/papers/40313573 | PubMed |
| 39918699 | Killed whole-cell Staphylococcus aureus formulation in Montanide ISA266 and Alum adjuvants: different vaccine formulations varied in the vaccine's potency and efficacy. | Immunol Res | 2025 | https://conductscience.org/library/papers/39918699 | PubMed |
| 39840071 | Designing a multi-epitope vaccine candidate against human rhinovirus C utilizing immunoinformatics approach. | Front Immunol | 2024 | https://conductscience.org/library/papers/39840071 | PubMed |
| 39765647 | Navigating Fish Immunity: Focus on Mucosal Immunity and the Evolving Landscape of Mucosal Vaccines. | Biology (Basel) | 2024 | https://conductscience.org/library/papers/39765647 | PubMed |
| 37993870 | Potentiating humoral and cellular immunity using a novel hybrid polymer-lipid nanoparticle adjuvant for HBsAg-VLP vaccine. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/37993870 | PubMed |
| 37816068 | Potentiating the Immune Responses of HBsAg-VLP Vaccine Using a Polyphosphoester-Based Cationic Polymer Adjuvant. | ACS Appl Mater Interfaces | 2023 | https://conductscience.org/library/papers/37816068 | PubMed |
| 37776767 | Nanoscale coordination polymer synergizes photodynamic therapy and toll-like receptor activation for enhanced antigen presentation and antitumor immunity. | Biomaterials | 2023 | https://conductscience.org/library/papers/37776767 | PubMed |
| 37631874 | Next-Generation TB Vaccines: Progress, Challenges, and Prospects. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37631874 | PubMed |
| 37534001 | Immunoinformatic and reverse vaccinology-based designing of potent multi-epitope vaccine against Marburgvirus targeting the glycoprotein. | Heliyon | 2023 | https://conductscience.org/library/papers/37534001 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24434331
GET https://conductscience.org/api/papers/v1/24434331/references?page=2